DJIA 17,083.80 -2.83 -0.02%
NASDAQ 4,472.11 -1.59 -0.04%
S&P 500 1,987.98 0.97 0.05%
market minute promo

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

CRTX 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.00





Cornerstone Therapeutics Inc. (CRTX) Description

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response. Website:

News & Commentary

Top Insider Trades: PSX YRCW CRTX IDIX

Insider Trading: Marc Lasry Boosts Stake in YRC Worldwide, Baupost Group Increases Idenix Holdings

Plus, a purchase at Cornerstone Therapeutics.

Cornerstone Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript

Osiris Shares Continue to Gain - Analyst Blog

Cornerstone Therapeutics Is Selling Itself Too Cheap

Cornerstone Therapeutics Is Selling Itself Too Short

What's Behind This Biotech's 40% Pop?

Shares of Discovery Labs jumped almost 40% on Friday. Find out what it means for the company as well as drug giant AbbVie and fellow specialty biotech Cornerstone Therapeutics.

Zacks #1 Rank Additions for Wednesday - Tale of the Tape

Law Firm Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduci

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cornerstone Therape

See More CRTX News...

CRTX's Top Competitors

CRTX 0.00 (0.00%)
Current stock: CRTX
AMGN $122.26 (0.20%)
Current stock: AMGN
GILD $90.54 (0.22%)
Current stock: GILD
BIIB $336.79 (-0.24%)
Current stock: BIIB